We use cookies to improve your experience and to help us understand how our site is used. You can find out more about your options on our
Cookies page.
About Cookies
Most websites these days use cookies to store and retrieve information. Some of this information might be about you,
your preferences or your device and is mostly used to help the website work in the way you expect.
This information doesn’t usually directly identify you but can give you a more personalized experience.
We will never sell any of your personally identifiable information, whether gathered using a cookie or otherwise.
We respect your right to privacy, so you can choose whether or not some cookies are enabled on our website.
However, disabling some cookies can impact your experience and the services we are able to offer. For more information see our Cookie settings and Privacy Policy.
Essential Cookies (Required)
These cookies are essential for the website to work properly and can’t be turned off.
They don’t collect personal information.
We also use them to understand how the site is used.
You can choose to block these cookies in your browser, but parts of the site might not work as expected.
Analytics Cookies (Optional)
These cookies help us improve our website and keep content relevant.
We use third-party tools to analyse information gathered by cookies and understand how visitors use our website.
We only use information gathered by cookies internally. See our Privacy Policy.
You can turn these cookies off by clicking "Reject optional cookies", but parts of the site might not work as expected.
Below is a text only representation of the Patient Information Leaflet (ePIL).
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PLGB 11972/0030.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is and what it is used for 2. What you need to know before you take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead 3. How to take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead 4. Possible side effects 5. How to store Sofosbuvir/Velpatasvir/Voxilaprevir Gilead 6. Contents of the pack and other information
If Sofosbuvir/Velpatasvir/Voxilaprevir Gilead has been prescribed for your child, please note that all the information in this leaflet is addressed to your child (in this case please read “your child” instead of “you”).
1. What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is and what it is used for
Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is a medicine that contains the active substances sofosbuvir, velpatasvir and voxilaprevir in a single tablet. It is given to treat a chronic (long-term) viral infection of the liver called hepatitis C in patients aged 12 years and older and weighing at least 30 kg.
The active substances in this medicine work together by blocking three different proteins that the hepatitis C virus needs to grow and reproduce itself, causing the infection to be eliminated from the body.
2. What you need to know before you take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
Do not take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
If you are allergic to sofosbuvir, velpatasvir, voxilaprevir or any of the other ingredients of this medicine (listed in section 6 of this leaflet).
If this applies to you, do not take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead and tell your doctor immediately.
If you are currently taking any of the following medicines:
rifampicin and rifabutin (antibiotics used to treat infections, including tuberculosis);
St. John’s wort (Hypericum perforatum) (a herbal medicine used to treat depression);
carbamazepine, phenobarbital and phenytoin (medicines used to treat epilepsy and prevent seizures);
rosuvastatin (a medicine used to treat high blood cholesterol or decrease the risk of certain cardiovascular events);
dabigatran etexilate (a medicine used to prevent blood clots);
ethinylestradiol containing medicines, including many contraceptives.
Warnings and precautions
Talk to your doctor if you:
have liver problems other than from hepatitis C, for instance
if you have a current or previous infection with the hepatitis B virus, since your doctor may want to monitor you more closely;
if you have had a liver transplant.
are taking treatment for human immunodeficiency virus (HIV) infection, since your doctor may want to monitor you more closely.
Talk to your doctor or pharmacist before taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead if:
you currently take, or have taken in the last few months, the medicine amiodarone to treat irregular heartbeats, as it may result in a life-threatening slowing of your heart beat. Your doctor may consider alternative treatments if you have taken this medicine. If treatment with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is needed, you may required additional heart monitoring.
you have diabetes. You may need closer monitoring of your blood glucose levels and/or adjustment of your diabetes medicines after starting Sofosbuvir/Velpatasvir/Voxilaprevir Gilead. Some diabetic patients have experienced low sugar levels in the blood (hypoglycaemia) after starting treatment with medicines like Sofosbuvir/Velpatasvir/Voxilaprevir Gilead.
Tell your doctor immediately if you currently take, or have taken in the last months, any medicines for heart problems and during treatment you experience:
slow or irregular heartbeat, or heart rhythm problems;
shortness of breath or worsening of existing shortness of breath;
chest pain;
light-headedness;
palpitations;
near fainting or fainting.
Blood tests
Your doctor will test your blood before, during and after your treatment with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead. This is so that:
Your doctor can decide if you should take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead and for how long;
Your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus.
Children and adolescents
Do not give this medicine to children under 12 years of age and weighing less than 30 kg. The use of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead in these patients has not yet been studied.
Other medicines and Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are not sure talk to your doctor or pharmacist.
Some medicines must not be taken with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead. Taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead with any of these may stop your medicines from working properly, or make any side effects worse:
rifampicin and rifabutin (antibiotics used to treat infections, including tuberculosis);
St. John’s wort (Hypericum perforatum) (a herbal medicine used to treat depression);
carbamazepine, phenobarbital and phenytoin (medicines used to treat epilepsy and prevent seizures);
rosuvastatin (a medicine used to treat high blood cholesterol or decrease the risk of certain cardiovascular events);
dabigatran etexilate (a medicine used to prevent blood clots);
ethinylestradiol containing medicines, including many contraceptives.
Tell your doctor or pharmacist if you are taking any of the medicines below:
amiodarone, used to treat irregular heartbeats;
rifapentine (an antibiotic used to treat infections, including tuberculosis);
oxcarbazepine (medicine used to treat epilepsy and prevent seizures);
tenofovir disoproxil fumarate, or any medicine containing tenofovir disoproxil fumarate, used to treat HIV infection;
atazanavir, efavirenz or lopinavir, used to treat HIV infection;
digoxin, used to treat heart conditions;
modafinil, used to treat sleep disorders;
atorvastatin, pravastatin, or other statins, used to treat high cholesterol;
ciclosporin, used to suppress the immune system.
Taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead with any of these may stop your medicines from working properly, or make any side effects worse. Your doctor may need to give you a different medicine or adjust the dose of medicine you are taking.
Get advice from a doctor or pharmacist if you take medicines used to treat stomach ulcers, heartburn or acid reflux as they can decrease the amount of velpatasvir in your blood. These medicines include:
antacids (such as aluminium/magnesium hydroxide or calcium carbonate). These should be taken at least 4 hours before or 4 hours after Sofosbuvir/Velpatasvir/Voxilaprevir Gilead;
proton pump inhibitors (such as omeprazole, lansoprazole, rabeprazole, pantoprazole and esomeprazole). If you need high doses of these medicines your doctor may give you a different medicine instead or adjust the dose of the medicine you are taking;
H2-receptor antagonists (such as famotidine, cimetidine, nizatidine or ranitidine). If you need high doses of these medicines your doctor may give you a different medicine instead or adjust the dose of the medicine you are taking.
These medicines can decrease the amount of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead in your blood. If you are taking one of these medicines your doctor will either give you a different medicine for stomach ulcers, heartburn or acid reflux, or recommend how and when you take that medicine.
Get advice from a doctor or pharmacist if you take warfarin or other similar medicines called vitamin K antagonists used to thin the blood. Your doctor may need to increase the frequency of your blood tests to check how well your blood can clot.
Your liver function may change with treatment of hepatitis C and therefore may affect other medicines (e.g. medicines used to suppress your immune system, etc.). Your doctor may need to closely monitor these other medicines you are taking and make adjustments after starting Sofosbuvir/Velpatasvir/Voxilaprevir Gilead.
Pregnancy, breast-feeding and fertility
If you are pregnant, think you may be pregnant, are breast-feeding your baby, or are planning to have a baby ask your doctor for advice before taking this medicine.
Pregnancy
Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is not recommended during pregnancy. The effects of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead during pregnancy are not known.
Breast-feeding
Do not breast-feed during treatment with Sofosbuvir/Velpatasvir/Voxilaprevir Gilead. Some of the active substances of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead may pass into human breast milk.
Driving and using machines
Sofosbuvir/Velpatasvir/Voxilaprevir Gilead should not affect your ability to drive or use any tools or machinery.
Tell your doctor if you are lactose intolerant or intolerant to other sugars. Sofosbuvir/Velpatasvir/Voxilaprevir Gilead contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium free’.
3. How to take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Recommended dose
The recommended dose of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead is one 400 mg/100 mg/100 mg tablet or two 200 mg/50 mg/50 mg tablets, taken once a day for 8 or 12 weeks.
Take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead as advised by your doctor.
Swallow the tablet(s) whole with food. Do not chew, crush or split the tablet as it has a very bitter taste.
Kidney problems
Tell your doctor if you have kidney problems or if you are on kidney dialysis, since Sofosbuvir/Velpatasvir/Voxilaprevir Gilead has not been fully tested in patients with severe kidney problems.
Liver problems
Sofosbuvir/Velpatasvir/Voxilaprevir Gilead should not be used if you have moderate or severe liver problems.
If you are taking an antacid, take it at least 4 hours before or at least 4 hours after Sofosbuvir/Velpatasvir/Voxilaprevir Gilead.
If you are sick (vomit) after taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead it may affect the amount of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead in your blood. This may make Sofosbuvir/Velpatasvir/Voxilaprevir Gilead work less well.
If you are sick (vomit) less than 4 hours after taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, take another dose.
If you are sick (vomit) more than 4 hours after taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, you do not need to take another dose until your next scheduled dose.
If you take more Sofosbuvir/Velpatasvir/Voxilaprevir Gilead than you should
If you accidentally take more than the recommended dose of Sofosbuvir/Velpatasvir/Voxilaprevir Gilead you may be at increased risk of side effects with this medicine (see section 4 Possible side effects).
Contact your doctor or nearest emergency department immediately for advice. Keep the tablet bottle with you so that you can easily describe what you have taken.
If you forget to take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
It is important not to miss a dose of this medicine.
If you do miss a dose, work out how long it is since you last took your Sofosbuvir/Velpatasvir/Voxilaprevir Gilead:
If you notice within 18 hours of the time you usually take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, you must take the missed dose as soon as possible. Then take the next dose at your usual time.
If it is 18 hours or more after the time you usually take Sofosbuvir/Velpatasvir/Voxilaprevir Gilead, wait and take the next dose at your usual time. Do not take a double dose (two doses close together) to make up for a forgotten dose.
Do not stop taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
Do not stop taking this medicine unless your doctor tells you to. It is very important that you complete the full course of treatment to give the medicine the best chance to treat your hepatitis C virus infection.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine may cause side effects, although not everybody gets them.
Some side effects could be serious.
Stop taking Sofosbuvir/Velpatasvir/Voxilaprevir Gilead and seek medical help immediately if you experience any of the following symptoms:
swelling of the face, lips, tongue or throat (angioedema) (an uncommon side effect - may affect up to 1 in 100 people)
a wide-spread severe rash with peeling skin which may be accompanied by fever, flu like symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson syndrome) (the frequency of the side effect is not known)
Other side effects that may occur
Very common side effects
(may affect more than 1 in 10 people)
headache
diarrhoea
feeling sick (nausea)
Common side effects
(may affect up to 1 in 10 people)
stomach pain
decreased appetite
being sick (vomiting)
muscle pain (myalgia)
abnormality in a laboratory test of liver function (total bilirubin)
rash
Uncommon side effects
(may affect up to 1 in 100 people)
muscle spasms
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Sofosbuvir/Velpatasvir/Voxilaprevir Gilead
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and carton after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from moisture. Keep the bottle tightly closed.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead contains
The active substances are sofosbuvir, velpatasvir and voxilaprevir. Each film-coated tablet contains 400 mg sofosbuvir, 100 mg velpatasvir and 100 mg voxilaprevir.
The other ingredients are Tablet core: Colloidal anhydrous silica, copovidone, croscarmellose sodium (E468) (see section 2 of this leaflet), lactose monohydrate (see section 2 of this leaflet) , magnesium stearate, microcrystalline cellulose (E460) Film-coating: Iron oxide black (E172), iron oxide red (E172), iron oxide yellow (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b), titanium dioxide (E171)
What Sofosbuvir/Velpatasvir/Voxilaprevir Gilead looks like and contents of the pack
Sofosbuvir/Velpatasvir/Voxilaprevir Gilead 400 mg/100 mg/100 mg film-coated tablets are beige, capsule-shaped tablets debossed with “GSI” on one side and “3” on the other side. The tablet is 20 mm long and 10 mm wide.
The tablets are packed in plastic bottles with child resistant caps. Each bottle contains a silica gel desiccant (drying agent) that must be kept in the bottle to help protect your tablets. The silica gel desiccant is contained in a separate sachet or canister and should not be swallowed.
The following pack size is available:
outer cartons containing 1 bottle of 28 film-coated tablets
Marketing Authorisation Holder
Gilead Sciences Ltd 280 High Holborn London WC1V 7EE United Kingdom
Manufacturer
Gilead Sciences Ireland UC IDA Business & Technology Park Carrigtohill County Cork Ireland
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: